Skip to Content
 

News: News Home Page Feature

New faculty profile: Tuya Pal, M.D.

Friday, October 27th, 2017

Tuya Pal, M.D., associate professor of medicine and Ingram Associate Professor of Cancer Research., specializes in cancer genetics and health disparities among diverse populations.

Lopez named Vanderbilt’s liaison to Oak Ridge National Laboratory

Saturday, September 2nd, 2017

Carlos F. Lopez, assistant professor of biochemistry and biomedical informatics, has been appointed as Vanderbilt University’s liaison to Oak Ridge National Laboratory, the U.S. Department of Energy’s largest science and energy laboratory conducting research in energy and security.

VICC’s annual Cancer Survivors Celebration set for Sept. 10

Monday, August 28th, 2017

Vanderbilt-Ingram Cancer Center (VICC) will host the 2017 Cancer Survivors Celebration Sunday, Sept. 10, from 2–4 p.m. This year’s free event, offered in partnership with Monroe Carell Jr. Children’s Hospital at Vanderbilt, will be held at the Vanderbilt Student Life Center, 310 25th Ave. South. “This year, to celebrate our community impacted by cancer, we’re […]

Cancer-fighting T cells are smarter, stronger than experts thought

Friday, August 18th, 2017

Scientists studying the body’s cancer-fighting T cells have a serious problem: When they culture them in the lab, the T cells sit around at equilibrium, waiting to bump into cancerous cells. But that’s not how they operate inside the body. There, they are motorized little bloodhounds, actively seeking out infected cells. In this active mode, […]

Early drivers of gastric cancer

Friday, August 11th, 2017

Gastric cancer – a leading cause of cancer-related deaths worldwide – is commonly diagnosed at a late stage when most patients have a poor prognosis. Wael El-Rifai, M.D., Ph.D., and colleagues are exploring the molecular alterations that drive gastric carcinogenesis, to improve early detection, treatment and prevention. They previously showed that knocking out (eliminating) the […]

Munyon named to new radiation therapy oversight board

Monday, August 7th, 2017

Karen Munyon, MBA, director of Finance and Operations for Radiation Oncology at Vanderbilt University Medical Center (VUMC), has been appointed to the Tennessee Radiologic Imaging and Radiation Therapy Board of Examiners. She is one of nine individuals appointed by the Tennessee governor or state lawmakers to the newly created oversight board. Karen Munyon, MBA While […]

Shyr named chair of Department of Biostatistics

Friday, July 21st, 2017

Yu Shyr, Ph.D., Harold L. Moses Professor of Cancer Research and director of the Vanderbilt Center for Quantitative Sciences, has been named chair of Vanderbilt’s Department of Biostatistics. He will assume the post Sept. 1. Yu Shyr, Ph.D. Shyr succeeds Frank Harrell Jr., Ph.D., professor of Biostatistics and founding chair of the department, who is […]

Bile acids, microbiota and colon cancer

Monday, July 10th, 2017

Deoxycholic acid (DCA), a secondary bile acid that is increased by high dietary fat intake – a western diet – has been linked to intestinal carcinogenesis. In a previous study, Fang Yan, M.D., Ph.D., and colleagues showed that DCA accelerated the progression of adenoma to adenocarcinoma in mice that spontaneously develop intestinal adenomas. Now, the researchers […]

VICC racers compete in downtown bed race for cancer research funding

Thursday, June 15th, 2017

Staff members from Vanderbilt-Ingram Cancer Center (VICC) garnered an impressive second place finish in last month’s Downtown Derby Bed Race competition. The annual event which raises funds for the T.J. Martell Foundation featured teams that built and decorated their own “beds” to race up 5th Avenue to Bridgestone Plaza in downtown Nashville. The VICC team, […]

Coffey lands major NCI award to support colorectal cancer research

Friday, June 9th, 2017

Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer. Robert Coffey Jr., M.D. Coffey, Ingram Professor of Cancer Research and […]

Next Page »« Previous Page